Ken A Olaussen

Ken A Olaussen

UNVERIFIED PROFILE

Are you Ken A Olaussen?   Register this Author

Register author
Ken A Olaussen

Ken A Olaussen

Publications by authors named "Ken A Olaussen"

Are you Ken A Olaussen?   Register this Author

19Publications

627Reads

23Profile Views

Facts and New Hopes on Selective FGFR Inhibitors in Solid Tumors.

Clin Cancer Res 2020 Feb 4;26(4):764-774. Epub 2019 Oct 4.

INSERM U981, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-2035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024606PMC
February 2020

Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?

Nat Rev Clin Oncol 2018 11;15(11):694-708

INSERM U981, Gustave Roussy Cancer Campus, Université Paris Saclay, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-018-0081-4DOI Listing
November 2018

Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer.

J Clin Oncol 2018 10 14;36(30):2995-3006. Epub 2018 Aug 14.

Siddhartha Devarakonda, Irena Lanc, and Ramaswamy Govindan, Washington University School of Medicine; Siddhartha Devarakonda and Ramaswamy Govindan, Siteman Cancer Center; Robert Fulton, Washington University School of Medicine, St. Louis; Ashiq Masood, University of Missouri Kansas City, Kansas City, MO; Federico Rotolo, Ken A. Olaussen, Gwénaël Le Teuff, Jean-Pierre Pignon, and Stefan Michiels, Université Paris-Saclay; Federico Rotolo, Ken A. Olaussen, Gwénaël Le Teuff, Jean-Pierre Pignon, Jean-Charles Soria, and Stefan Michiels, Gustave Roussy Cancer Campus, Villejuif; Elisabeth Brambilla and Anne McLeer-Florin, Centre Hospitalier Universitaire de Grenoble, La Tronche, France; Ming-Sound Tsao, Shingo Sakashita, and Frances A. Shepherd, Princess Margaret Cancer Centre and University of Toronto, Toronto; Keyue Ding and Lesley Seymour, Queen's University Kingston, Ontario, Canada; Stephen L. Graziano, State University of New York Upstate Medical University, Syracuse, NY; Robert Kratzke, University of Minnesota Medical School, Minneapolis, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.1963DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804865PMC
October 2018

A novel antibody-based approach to detect the functional ERCC1-202 isoform.

DNA Repair (Amst) 2018 04 11;64:34-44. Epub 2018 Feb 11.

INSERM U981, Gustave Roussy, 94805, Villejuif, France; Faculté de médecine, Université Paris-Sud, 94270, Kremlin-Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dnarep.2018.02.002DOI Listing
April 2018

ERCC1 and RRM1: ready for prime time?

J Clin Oncol 2013 Mar 11;31(8):1050-60. Epub 2013 Feb 11.

Université Paris Sud, Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.43.0900DOI Listing
March 2013

The potential of exploiting DNA-repair defects for optimizing lung cancer treatment.

Nat Rev Clin Oncol 2012 Feb 14;9(3):144-55. Epub 2012 Feb 14.

INSERM U981, Department of Medicine, Université Paris-Sud XI-Institut Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2012.3DOI Listing
February 2012

MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancer.

Clin Cancer Res 2010 Feb 9;16(4):1206-15. Epub 2010 Feb 9.

Department of Medicine, Biostatistics and Epidemiology Unit, Translational Research Laboratory, Paris-Sud University, Gustave-Roussy Institute, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-2204DOI Listing
February 2010

ERCC1-specific immunostaining in non-small-cell lung cancer.

N Engl J Med 2007 Oct;357(15):1559-61

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc072007DOI Listing
October 2007